OKYO Pharma OKYO
NASDAQ OKYO
$1.46 -0.07 (-4.61%)
As of: Sep 9, 2026 · 3:59 PM EDT

OKYO Pharma (OKYO) Change in Account Payables (2024 - 2026)

OKYO Pharma's (OKYO) quarterly Change in Account Payables came in at -$853810.0 in Q1 2026, down 146.02% quarter-over-quarter from $1.9 million in Q4 2025.

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo
Analysis

OKYO Pharma (OKYO) Change in Account Payables (2024 - 2026) Analysis & Trends

OKYO Pharma (OKYO) has reported Change in Account Payables for 3 consecutive years, with -$853810.0 the latest figure, recorded in Q1 2026.

Peer Set

Peer Comparison

All peers
# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -70.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 18.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -66.70 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -8.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 7.11 Mn
10 OKYO Pharma 985.60 Mn 985.60 Mn - -853,810.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -853,810.00
Dec 31, 2025 1.86 Mn
Dec 31, 2024 2.80 Mn